1 / 6

Antibody Production Market Size, Top Companies, Market Demand, Industry Challenges and Opportunities to 2026

Rising incidence of contagious diseases is a major factor influencing market growth.<br><br>

Elesmith
Download Presentation

Antibody Production Market Size, Top Companies, Market Demand, Industry Challenges and Opportunities to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antibody Production Market To Reach USD 26.16 Billion By 2026 www.reportsanddata.com sales@reportsanddata.com

  2. Market Summary Rising incidence of contagious diseases is a major factor influencing market growth. Antibody Production Market Size – USD 9.72 billion in 2018, Market Growth - CAGR of 13.1 %, Market Trends –Rise in targeted immunotherapy adoption, along with an increase in R&D investment of biotechnology and pharmaceutical companies

  3. Our Approach Market Summary The Antibody production market is expected to reach USD 26.16 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the increasing prevalence of contagious diseases globally, coupled with the expanding demand for protein therapeutics, which is promoting the development of the global market. The clinical and commercial progress of monoclonal antibodies has resulted in the need for production of antibodies in mammalian cell culture on a large-scale. Based on statistics, the rise in targeted immunotherapy adoption along with enhanced acceptance by regulatory authorities for therapeutic antibodies and an increase in R&D investment of biotechnology and pharmaceutical companies stimulate the growth of the global market. Also, the rise in the prevalence of infectious diseases and growth in demand for protein therapeutics is expected to spur the market growth further. However , expensive primary antibodies will restrain the growth. Antibodies also acknowledged as immunoglobulins, are abundant Y-shaped proteins that are generated by plasma cells, and are utilized by the immune system to neutralize pathogens such as viruses and bacteria. The immune system responds to external materials or antigens penetrating inside the body by producing antibodies. The two main types of antibodies are polyclonal and monoclonal antibodies, which can also be produced by techniques like hybridoma. Key participants include Thermo Fisher Scientific, Inc., GeneTex, Inc., Eli Lilly and Company, Pall Corporation, Merck KGaA, Eppendorf AG, Cellab GmbH, Abcam PLC, and Sigma-Aldrich Corporation FiberCell Systems Inc., among others. To Get Sample Copy of Report visit: https://www.reportsanddata.com/sample-enquiry-form/1404

  4. Our Approach Market Summary Class Outlook (Revenue, USD Million; 2016-2026) Monoclonal antibodies Murine Chimeric Humanized Polyclonal Antibodies End User Outlook (Revenue, USD Million; 2016-2026) Pharmaceutical & Biotechnology Companies Diagnostic Laboratories Research Institutes Process Outlook (Revenue, USD Million; 2016-2026) Upstream Processing Downstream Processing Filtration Any Query or Discount? Ask our Expert @ https://www.reportsanddata.com/discount-enquiry-form/1404

  5. Our Approach Market Summary Further key findings from the report suggest The therapeutics are incredibly useful for treating cancer, rheumatoid arthritis, and other chronic diseases The growing incidence of contagious diseases, coupled with expanding demand for protein therapeutics is expected to drive the growth of the market. Other factors that are responsible for the growth of the market are raised R&D disbursement on biotechnology and pharmaceutical companies, the patent cessation of prosperous monoclonal antibodies, therapeutic antibodies by governing authorities, and acceptance of targeted immunotherapy. The monoclonal class segment is estimated to reach USD 10.33 billion by 2026 at a CAGR of 13.2% during the forecast period. Due to the growing demand in the treatment of chronic diseases including blood disorders, cancer, and growth hormone deficiency, this segment is expected to hold a significant share during the forecast period. This downstream procedure includes the application of accurate, highly sophisticated, and effective products that include chromatography instruments & resins. The potency of cell cultures has increased over the past decade, leading to process optimization and improved yield. Read More @ https://www.reportsanddata.com/report-detail/antibody-production-market

  6. Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Our Approach About Us

More Related